These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 30101709)
21. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases. Kreutzer AG; Nowick JS Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological treatment for Alzheimer's disease: current approaches and future strategies. Fan LY; Chiu MJ Acta Neurol Taiwan; 2010 Dec; 19(4):228-45. PubMed ID: 21213151 [TBL] [Abstract][Full Text] [Related]
23. [Recent progress in the development of disease-modifying therapies for Alzheimer's disease]. Abe K Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Feb; 30(1):1-8. PubMed ID: 20297736 [TBL] [Abstract][Full Text] [Related]
24. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease. Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994 [TBL] [Abstract][Full Text] [Related]
32. DOTA: Deep Learning Optimal Transport Approach to Advance Drug Repositioning for Alzheimer's Disease. Chyr J; Gong H; Zhou X Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204697 [TBL] [Abstract][Full Text] [Related]
34. Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice. Alves S; Churlaud G; Audrain M; Michaelsen-Preusse K; Fol R; Souchet B; Braudeau J; Korte M; Klatzmann D; Cartier N Brain; 2017 Mar; 140(3):826-842. PubMed ID: 28003243 [TBL] [Abstract][Full Text] [Related]
35. Alzheimer's disease: progress in the development of anti-amyloid disease-modifying therapies. Christensen DD CNS Spectr; 2007 Feb; 12(2):113-6, 119-23. PubMed ID: 17277711 [TBL] [Abstract][Full Text] [Related]
36. The past, present, and future of disease-modifying therapies for Alzheimer's disease. Suzuki K; Iwata A; Iwatsubo T Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(10):757-771. PubMed ID: 29225305 [TBL] [Abstract][Full Text] [Related]
37. Drug development status for Alzheimer's disease: present scenario. Misra S; Medhi B Neurol Sci; 2013 Jun; 34(6):831-9. PubMed ID: 23392897 [TBL] [Abstract][Full Text] [Related]
38. Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease. Kim TW Neurotherapeutics; 2015 Jan; 12(1):132-42. PubMed ID: 25549849 [TBL] [Abstract][Full Text] [Related]